Anmeldung erfolgt in Kürze...
Details werden geladen...
Moderna, Merck say mRNA treatment cuts risk of melanoma recurrence, spread - CNA
US pharma giants Moderna and Merck have scored a breakthrough in a vaccine that could allow people with a type of skin cancer to live longer. The companies say their vaccine reduced the risk of recurrence and spread of melanoma, the deadliest form of skin cancer. It is the first positive final-stage trial for any mRNA-
Ähnliche Seiten
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.brisbanetimes.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html?ref=rss&utm_medium=rss&utm_source=rss_feed
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.smh.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.theage.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html?ref=rss&utm_medium=rss&utm_source=rss_feedModerna cancer vaccine: mRNA treatment trial reduces risk of melanoma recurrence and spread
https://www.theage.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.watoday.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html?ref=rss&utm_medium=rss&utm_source=rss_feed